MET and colorectal carcinoma: Thus, the study comprehensively validated the pure OC and OC-rich EVOO-derived polyphenol rich fraction (PPRF) as orally effective anti-CRC progression and recurrence leads by targeting SMYD2-EZH2 expression and c-MET activation.